02 July 2004
Comparison of intrathecal levobupivacaine with and without fentanyl in combined spinal epidural for labor analgesia
Yvonne Lim, Alex T. Sia, Cecilia E. OcampoMed Sci Monit 2004; 10(7): PI87-91 :: ID: 11713
Abstract
Background:The initiation of epidural infusion immediately after intrathecal (IT) injection to prolong labor analgesia has gained increasing popularity. The effect of additional intrathecal fentanyl on levobupivacaine for labor analgesia has not been fully investigated. We wished to determine if addition of IT fentanyl to IT levobupivacaine in combined spinal epidural (CSE) could prolong obstetric analgesia when epidural infusion is initiated promptly.Material/Methods:In this randomized controlled trial, 40 nulliparous parturients in labor were recruited to receive either IT 2.5 mg levobupivacaine (L) or IT 2.5 mg levobupivacaine + 25 ml/h epidural infusion of 0.125% levobupivacaine and 2 x2 test and Kaplan-Meier technique (using a log-rank test), respectively. Sensory block, motor block, pain scores, and post-block side effects were also evaluated.Results:The percentage of parturients with ‘successful’ blocks, i.e. parturients not requiring further analgesic supplementation, was significantly higher in LF (87.5% vs. 44%, p<0.05). The duration of analgesia was also significantly longer in group LF (mean 530 min ±SE65 vs. 361±66, p<0.05).
Conclusions: The addition of 25 µg intrathecal fentanyl to 2.5 mg levobupivacaine as part of CSE for labor analgesia decreased the incidence of labor breakthrough pain and resulted in a longer duration of labor pain relief. This may decrease the need for supplemental labor pain relief and the anesthetists’ workload in the delivery suite.
Keywords: Analgesia, Epidural - adverse effects, Analgesia, Epidural - methods, Analgesia, Obstetrical - adverse effects, Analgesia, Obstetrical - methods, Bupivacaine - administration & dosage, Bupivacaine - adverse effects, Bupivacaine - analogs & derivatives, Fentanyl - administration & dosage, Fentanyl - adverse effects, Injections, Spinal, Labor Stage, First, Oxytocin - administration & dosage, Pain Measurement - drug effects, Parturition, Patient Satisfaction, Pregnancy, Analgesia, Epidural - methods, Analgesia, Obstetrical - methods, Bupivacaine - analogs & derivatives, Fentanyl - adverse effects, Injections, Spinal, Labor Stage, First, Oxytocin - administration & dosage, Pain Measurement - drug effects, Parturition, Patient Satisfaction, Pregnancy
Editorial
01 February 2025 : Editorial
Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-SmokersDOI: 10.12659/MSM.948255
Med Sci Monit 2025; 31:e948255
In Press
Review article
Hydrogels in Oral Disease Management: A Review of Innovations in Drug Delivery and Tissue RegenerationMed Sci Monit In Press; DOI: 10.12659/MSM.946122
Clinical Research
Procedure Dynamics in Transfemoral vs Transradial Cerebral Angiography: A Retrospective StudyMed Sci Monit In Press; DOI: 10.12659/MSM.947603
Clinical Research
Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemi...Med Sci Monit In Press; DOI: 10.12659/MSM.946303
Clinical Research
Long-Term Outcomes of Implanon in Managing Adenomyosis: A 3-Year Prospective StudyMed Sci Monit In Press; DOI: 10.12659/MSM.945972
Most Viewed Current Articles
17 Jan 2024 : Review article 6,969,459
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 701,879
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 25,628
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 20,173
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912